# OnCo record flt3i-plus-7-3 (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/flt3i-plus-7-3/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "flt3i-plus-7-3" ;
  schema:name "FLT3 inhibitor + intensive chemotherapy"@en ;
  schema:description "Adding a FLT3 blocker to standard chemotherapy is the proven way to improve survival in FLT3-mutated AML."@en ;
  schema:url <https://onco.cc/pairings/flt3i-plus-7-3/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00651261>, <https://clinicaltrials.gov/study/NCT02668653> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:drugs <https://onco.cc/drugs/midostaurin/>, <https://onco.cc/drugs/quizartinib/>, <https://onco.cc/drugs/gilteritinib/>, <https://onco.cc/drugs/cytarabine-7-3/> ;
  onco:trials <https://onco.cc/trials/ratify/>, <https://onco.cc/trials/quantum-first/> ;
  onco:pairs <https://onco.cc/drugs/quizartinib/>, <https://onco.cc/drugs/cytarabine-7-3/> .
